烟草吸烟暴露和临床结果在坟墓的疾病
Sarah Forbes1, May Loo1, Su Ann Tee1
1Department of Endocrinology, Gateshead Health NHS Foundation Trust, Gateshead, NE9 6SX, United Kingdom.
The Journal of clinical endocrinology and metabolism
|February 12, 2026
概括
吸烟会以剂量取决的方式增加格雷夫斯病 (GD) 的严重程度,自身免疫力和复发风险. 戒烟或减少吸烟量显著改善了结果,前吸烟者表现出与非吸烟者相似的风险.
科学领域:
- 内分泌学 在内分泌学.
- 自身免疫性疾病是一种自身免疫性疾病.
- 公共卫生 公共卫生
背景情况:
- 吸烟是格雷夫斯病 (GD) 的已知危险因素之一.
- 吸烟和GD严重程度,自身免疫力和治疗后复发之间的确切定量关系仍然不清楚.
研究的目的:
- 调查吸烟暴露与格雷夫斯病患者的关键临床结果之间的剂量依赖关系.
主要方法:
- 一项观察性队列研究在英国二级护理内分泌学服务中进行.
- 包括991名新诊断的GD成年患者;663人停止服用抗甲状腺药物 (ATD) 后完成了随访.
- 收集的数据包括吸烟状态,香烟消费,TRAb水平,甲状腺激素,轨道病变和ATD后复发率.
主要成果:
- 与非吸烟者相比,目前吸烟者表现出更高的TRAb水平和更高的轨道病变几率.
- 每增加10支香烟/天都与更高的轨道病变几率和60%的12个月复发风险增加有关.
- 吸烟与ATD戒断时的TRAb水平较高有关,而ATD戒断后的早期复发风险最高.
结论:
- 吸烟与增加的自身免疫活性,更高的轨道病变风险,以及在格雷夫斯病中更高的复发率有关.
- 戒烟或减少吸烟是改善GD结果的关键干预措施.
- 前吸烟者表现出与非吸烟者相比的风险,加强了戒烟的好处.
相关概念视频
COPD: Pathogenesis and Clinical Features
2.1K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K
Hyperthyroidism I: Introduction
30
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
30
Hyperthyroidism II: Pathophysiology
28
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
28
Graves' Disease I: Introduction
23
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
23
Graves Disease II: Pathophysiology
26
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
26
Goiter
32
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
32


